* Joint Corp JYNT.OQ reported a quarterly adjusted loss
of 21
cents per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of -5
cents. The mean expectation of five analysts for the quarter
was for earnings of one cent per share. Wall Street expected
results to range from -5 cents to 8 cents per share.
* Revenue rose 2.5% to $30.20 million from a year ago;
analysts
expected $28.38 million.
* Joint Corp's reported EPS for the quarter was a loss of 21
cents.
* The company reported a quarterly loss of $3.17 million.
* Joint Corp shares had risen by 3.8% this quarter and
gained 23.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 18.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"
Wall Street's median 12-month price target for Joint Corp is
17.50
This summary was machine generated from LSEG data November 8 at
09:06 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.01 -0.21 Missed
Jun. 30 2024 -0.02 -0.13 Missed
Mar. 31 2024 -0.01 0.06 Beat
Dec. 31 2023 0.01 -0.75 Missed